S&P 500 rises on economic recovery and vaccine hopes, pulls back from highs

U.S. stocks closed higher on Tuesday on optimism about the development of coronavirus vaccines and a revival of business activity, but the S&P 500 failed to hold above the key psychological level of 3,000 points.